Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania : a randomized, single-blinded clinical trial

Richard Mwaiswelo,Billy Ngasala,Irina Jovel,Berit Aydin-Schmidt,Roland D. Gosling,Zul Premji,Bruno P. Mmbando,Anders Björkman,Andreas Mårtensson

Adding a single low-dose of primaquine (0.25 mg/kg) to artemether-lumefantrine did not compromise treatment outcome of uncomplicated Plasmodium falciparum malaria in Tanzania : a randomized, single-blinded clinical trial

2016

Richard Mwaiswelo
Billy Ngasala
Irina Jovel
Berit Aydin-Schmidt
Roland D. Gosling
Zul Premji
Bruno P. Mmbando
Anders Björkman
Andreas Mårtensson

Background: The World Health Organization (WHO) recently recommended the addition of a single low-dose of the gametocytocidal drug primaquine (PQ) to artemisinin-based combination therapy (ACT) in ...

Keywords:

Clinical trial
Primaquine
Immunology
Compromise
Artemether/lumefantrine
Combination therapy
Plasmodium falciparum
Artemisinin
Malaria
Medicine
Tanzania

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations